Home/Filings/4/0001209191-18-025664
4//SEC Filing

Masciantonio Ronald James 4

Accession 0001209191-18-025664

CIK 0000896985other

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 12:10 PM ET

Size

19.5 KB

Accession

0001209191-18-025664

Insider Transaction Report

Form 4
Period: 2018-04-20
Masciantonio Ronald James
EVP & General Counsel
Transactions
  • Award

    Stock Options (Right to Buy)

    2018-04-20+35,00035,000 total
    Exercise: $2.65Exp: 2028-04-20Common Stock (35,000 underlying)
  • Award

    Common Stock

    2018-04-20+35,000159,723 total
Holdings
  • Stock Options (Right to Buy)

    Exercise: $7.49Exp: 2026-03-30Common Stock (56,072 underlying)
    56,072
  • Stock Options (Right to Buy)

    Exercise: $22.13Exp: 2021-03-03Common Stock (9,000 underlying)
    9,000
  • Stock Options (Right to Buy)

    Exercise: $30.50Exp: 2023-12-04Common Stock (7,788 underlying)
    7,788
  • Stock Options (Right to Buy)

    Exercise: $14.51Exp: 2021-11-18Common Stock (4,882 underlying)
    4,882
  • Stock Options (Right to Buy)

    Exercise: $19.89Exp: 2022-11-16Common Stock (7,744 underlying)
    7,744
  • Stock Options (Right to Buy)

    Exercise: $14.30Exp: 2024-12-05Common Stock (75,353 underlying)
    75,353
  • Stock Options (Right to Buy)

    Exercise: $11.89Exp: 2020-01-29Common Stock (12,000 underlying)
    12,000
Footnotes (10)
  • [F1]On April 20, 2018, 35,000 shares of restricted stock were issued to the Reporting Person by the Issuer. These shares vest in four (4) equal annual installments beginning on April 20, 2019.
  • [F10]On April 20, 2018, options to purchase 35,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on April 20, 2019. All of the April 20, 2018 options are unvested.
  • [F2]Includes 142,877 shares of unvested restricted stock. This includes 35,000 shares of unvested restricted stock granted to the Reporting Person on April 20, 2018, which shares vest in four (4) equal annual installments beginning on April 20, 2019, 100,000 shares from the October 19, 2017 grant of 100,000 shares, which shares vest in four (4) equal annual installments beginning on October 19, 2018; 2,035 shares from the December 5, 2014 grant of 8,138 shares, which shares vest in four (4) annual installments beginning on December 5, 2015 as follows: 2,034 shares vest on each of December 5, 2015 and December 5, 2017, and 2,035 shares vest on each of December 5, 2016 and December 5, 2018; and 5,842 shares from the March 30, 2016 grant of 11,683 shares, which shares vest in four (4) annual installments beginning on March 30, 2017 as follows: 2,920 shares vest on March 30, 2017, and 2,921 shares vest on each of March 30, 2018, March 30, 2019, and March 30, 2020.
  • [F3]On January 29, 2010, options to purchase 30,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on January 29, 2011. All of the remaining outstanding January 29, 2010 options are vested.
  • [F4]On March 3, 2011, options to purchase 15,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on March 3, 2012. All of the remaining outstanding March 3, 2011 options are vested.
  • [F5]On November 18, 2011, options to purchase 9,764 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 18, 2012. All of the remaining outstanding November 18, 2011 options are vested.
  • [F6]On November 16, 2012, options to purchase 10,325 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on November 16, 2013 as follows: 2,581 options vest on each of November 16, 2013, November 16, 2014, and November 16, 2015, and 2,582 options vest on November 16, 2016. All of the remaining outstanding November 16, 2012 options are vested.
  • [F7]On December 4, 2013, options to purchase 7,788 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on December 4, 2014. All of the outstanding December 4, 2013 options are vested.
  • [F8]On December 5, 2014, options to purchase 75,353 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) annual installments beginning on December 5, 2015 as follows: 18,838 options vest on each of December 5, 2015, December 5, 2016, and December 5, 2017, and 18,839 options vest on December 5, 2018. 56,514 of the outstanding December 5, 2014 options are vested and 18,839 are unvested.
  • [F9]On March 30, 2016, options to purchase 56,072 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on March 30, 2017. 28,036 of the outstanding March 30, 2016 options are vested and 28,036 are unvested.

Issuer

Destination Maternity Corp

CIK 0000896985

Entity typeother

Related Parties

1
  • filerCIK 0001518858

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 12:10 PM ET
Size
19.5 KB